Cargando…
Formulation and evaluation of olanzapine matrix pellets for controlled release
BACKGROUND AND THE PURPOSE OF THE STUDY: Olanzapine is an antipsychotic used in treatment of schizophrenia. This research was carried out to design oral controlled release matrix pellets of water insoluble drug Olanzapine (OZ), using blend of Sodium Alginate (SA) and Glyceryl Palmito-Stearate (GPS)...
Autores principales: | Vishal Gupta, N., Gowda, DV., Balamuralidhara, V., Mohammed Khan, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304385/ https://www.ncbi.nlm.nih.gov/pubmed/22615665 |
Ejemplares similares
-
In Situ Co-Amorphization of Olanzapine in the Matrix and on the Coat of Pellets
por: da Costa, Nuno F., et al.
Publicado: (2022) -
Amorphous and Co-Amorphous Olanzapine Stability in Formulations Intended for Wet Granulation and Pelletization
por: da Costa, Nuno F., et al.
Publicado: (2022) -
Formulation and evaluation of sustained release enteric-coated pellets of budesonide for intestinal delivery
por: Raval, Mihir K, et al.
Publicado: (2013) -
Preparation and Comparative Bioavailability Studies of Indomethacin-Loaded Cetyl Alcohol Microspheres
por: Gupta, N. Vishal, et al.
Publicado: (2013) -
Evaluation of Bioequivalence of Two Oral Formulations of Olanzapine
por: Singhal, R., et al.
Publicado: (2011)